Found 6 matching trials
A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes
PHASE1This will be a 2-week oral dose study of PF 04991532, performed in patients...
Location
Pfizer Investigational Site
Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes
PHASE2B2611003 is designed to study how safe and effective an investigational med...
Location
Pfizer Investigational Site
Single Dose Study of PF-04991532 in Healthy Subjects
PHASE1The purpose of this study is to characterize the safety, tolerability, phar...
Location
Pfizer Investigational Site
Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes
PHASE1The purpose of this study is to characterize the safety, tolerability, phar...
Location
Pfizer Investigational Site
Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532
PHASE1The primary purpose of this study is to evaluate the pharmacokinetics, safe...
Location
Pfizer Investigational Site
A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532
PHASE1This study is to investigate the safety, tolerability and pharmacokinetics ...
Location
Pfizer Investigational Site